Try our Advanced Search for more refined results
Intellectual Property
-
October 17, 2024
USPTO Told More Clarity Needed On AI And Patent Eligibility
Numerous companies and industry groups have said they welcome the U.S. Patent and Trademark Office's new guidance on when inventions involving artificial intelligence are eligible for patents, but many urged the agency to provide additional clarity and practical examples.
-
October 17, 2024
Microsoft Fights IP, Antitrust Suit Alleging Cartel With Nvidia
Microsoft slammed a lawsuit brought by a startup accusing it, Nvidia and a third company of engaging in patent infringement and an illegal buyers' cartel suppressing the price of graphic processing units used in powering artificial intelligence, urging a Texas federal judge Wednesday to deny an injunction bid due to lack of evidence.
-
October 17, 2024
How Muhammad Ali's Ex-Photog Won $2.7M From Brand Co.
When Muhammad Ali's former personal photographer brought a copyright suit against a powerful brand management company, his attorneys faced a daunting challenge at trial: How can they convince jurors that Authentic Brands Group was liable for willful infringement?
-
October 17, 2024
Gov't Tells Justices To Reject Return Mail's Alice Petition
The federal government says the U.S. Supreme Court should not hear a small Alabama company's appeal of a lower court's invalidation of claims in its patent on processing undeliverable mail, arguing that the claims were not patent eligible.
-
October 17, 2024
Hospital Can Use TM Fraud Claim As Shield, Not Sword
A North Carolina hospital and healthcare provider can't pursue a trademark fraud counterclaim in a weight loss clinic's infringement dispute but can assert the claim as an affirmative defense, a federal judge ruled.
-
October 17, 2024
Justices Urged To Fix 'Novel Misreading' Of IP Safe Harbor
Edwards Lifesciences is asking the U.S. Supreme Court to rein in what's covered under a drug-development safe harbor to avoid patent infringement, saying the Federal Circuit wrongfully expanded it in a "novel misreading" of the law.
-
October 17, 2024
Cisco Foe Takes Computer Security Patent Feud To Fed. Circ.
A cybersecurity startup that saw its multibillion-dollar patent win against Cisco erased is pinning the failure, in part, on a new judge's "eleventh-hour, sua sponte claim construction" and is asking the Federal Circuit to overturn it.
-
October 17, 2024
Northwestern Hits Moderna With Patent Suit Over COVID Vax
Northwestern University has launched a patent infringement lawsuit in Delaware federal court accusing Moderna of wrongly taking research that the school did when the company was making its COVID-19 vaccine.
-
October 17, 2024
Texans Say Rapper Is Tripping With Suit Over 'Still Tippin'
The Houston Texans are asking a Texas federal judge to toss a suit lodged by a rapper who claims the NFL team stole his song, "Still Tippin," characterizing his claims as "frivolous" and "not viable."
-
October 17, 2024
Jury Says Phillips 66 Owes $605M In Fuel Trade Secrets Fight
A jury in California state court said Wednesday a retailer of low-carbon fuels is owed $604.9 million after finding that Phillips 66 swiped trade secrets relating to data, such as sales information and pricing methods.
-
October 17, 2024
Google Asks 9th Circ. To Immediately Pause Epic Injunction
Google filed an emergency motion late Wednesday in its antitrust battle with Epic Games Inc. asking the Ninth Circuit to stay a lower court's injunction that's set to take effect Nov. 1 requiring Google to open up its Play Store to competing app stores, slamming the injunction as harmful and "unworkable."
-
October 17, 2024
Moderna Wants Fees For 'Frivolous' COVID-19 Vax Suit
Moderna is asking a Delaware federal judge to award it about $2.8 million in legal costs for its defense of claims in a patent suit brought by Alnylam Pharmaceuticals over its coronavirus vaccine, arguing the Boston-based company pursued "frivolous" claims that wasted court resources.
-
October 17, 2024
Industrial Pipe Co. Hits Rival, Ex-Exec With Trade Secrets Suit
Industrial pipe manufacturer Atkore International Inc. took one of its former senior-level executives and the rival company he went to work for to North Carolina state court, alleging the former employee sabotaged operations on his way out the door and took valuable trade secrets with him.
-
October 17, 2024
Randy Newman Sells Music Rights To Carlyle-Backed Litmus
Musician and songwriter Randy Newman has sold his stake in his recorded music and publishing rights to Carlyle-backed music rights business Litmus Music, a transaction that includes decades of popular recordings and music from feature films, including the song "You've Got A Friend In Me" from 1995's "Toy Story," Litmus said Thursday.
-
October 16, 2024
Spex Jury Can't Use Kingston Deal To Calculate IP Damages
A California federal judge ruled Wednesday that jurors deciding whether Western Digital infringed Spex Technologies' data security patent can't consider Spex's 2009 licensing agreement with Kingston Technology to calculate potential damages, since there was no way to tease the value of the patent-at-issue out of the broader deal.
-
October 16, 2024
Nike Still Owes Fees In 'Cool Compression' TM Case
A Pennsylvania federal judge on Wednesday ruled for a second time that Nike is on the hook for legal fees in a trademark lawsuit after the Third Circuit ordered him to take a closer look at the details of the case to determine if the outcome was truly "exceptional."
-
October 16, 2024
Philips Says $12M Sanction Needed For Evidence Destruction
A spoliation sanctions hearing for around $12 million in royalty damages turned terse when the owner of a medical device equipment sale and servicing company seemingly hedged his statements, with a Texas federal judge saying, "Oh my gosh, just answer the question," during the Wednesday hearing.
-
October 16, 2024
Apple Heart Rate Monitor Patent Survives PTAB
An administrative patent board has decided not to invalidate an Apple patent that the tech giant once asserted in its ongoing fight with a company in the smartwatch space.
-
October 16, 2024
Judge Orders 'Starbuds' Co. To Grind Down Logo And Name
A federal judge in Manhattan has ordered a cannabis food truck to destroy all of its "Starbuds" logos, after siding with coffee giant Starbucks Corp. in a copyright infringement lawsuit.
-
October 16, 2024
Photog Tells 9th Circ. Miles Davis Tattoo Was Not Fair Use
A photographer wants the Ninth Circuit to undo a California federal jury's finding that cleared celebrity tattoo artist Kat Von D of claims she infringed a copyrighted photo of Miles Davis that he took, saying she failed to adequately show fair use.
-
October 16, 2024
Bacardi Fends Off Cuban Co.'s 'Havana Club' TM Claim
A D.C. federal judge tossed a Cuban state-owned company's counterclaim accusing Bacardi of infringing its "Havana Club" trademark, saying U.S. law barred the court from enforcing the mark.
-
October 16, 2024
NC Beach Canopy Co. Throws Shade At Rival In Patent Suit
A North Carolina-based beach canopy maker claims another Tar Heel State company has ignored its request to stop making a product that allegedly infringes a patent for its shading system.
-
October 16, 2024
Mich. Panel Sinks Inventor's Atty Malpractice Appeal
A Michigan appellate panel has held that the inventor of a swim training device did not prove he would have built a successful custom swim paddle business had his attorney secured him a patent, affirming the dismissal of a legal malpractice suit against the inventor's patent attorney and firm.
-
October 16, 2024
PTAB Refuses To Review Pioneer Corn Seed Patent
The Patent Trial and Appeal Board has said it won't review a challenge to a plant utility patent owned by a unit of a DowDuPont spin-off, handing another loss to a Massachusetts plant breeding startup in a larger legal fight over seed patents between the companies.
-
October 16, 2024
AAM, Alvogen Back Sun Pharma In Double Patenting Row
A trade group representing generic-drug makers, a generic-drug company and a plant-breeding technology business have all thrown their support behind Sun Pharmaceutical Industries' bid for the full Federal Circuit to take a closer look at the issue of double patenting.
Expert Analysis
-
Navigating The Murky Waters Of Patent Infringement Damages
Recent cases show that there is no easy way to isolate an infringed patent’s value, and it would serve all sides well for courts to thoroughly examine expert opinions of this nature and provide consistent guidance for future cases, say Manny Caixeiro and Elizabeth Manno at Venable.
-
Lawyers Can Take Action To Honor The Voting Rights Act
As the Voting Rights Act reaches its 59th anniversary Tuesday, it must urgently be reinforced against recent efforts to dismantle voter protections, and lawyers can pitch in immediately by volunteering and taking on pro bono work to directly help safeguard the right to vote, says Anna Chu at We The Action.
-
3rd Circ. Ruling Shows Benefits Of IP Licenses In Bankruptcy
The Third Circuit’s recent ruling in Mallinckrodt’s Chapter 11 filing, which held that Mallinckrodt could sever its obligations to pay Sanofi royalties on sales of an autoimmune disease drug, highlights the advantages of structuring transactions as nonexclusive licenses for developers of intellectual property, say Gregory Hesse and Kaleb Bailey at Hunton.
-
Opinion
Unclear Intellectual Property Laws Are Stifling US Innovation
U.S. intellectual property law’s lack of predictability means far less job-creating investments for companies that need patent protection to compete, and Congress must step in with legislation like the Patent Eligibility Restoration Act to help address the problem, says Michael Gulliford at Soryn IP Capital Management.
-
The Fed. Circ. In June: More Liability For Generic-Drug Makers
The Federal Circuit’s June ruling in Amarin v. Hikma will likely result in more allegations of induced infringement by generic drugs postapproval, with more of those cases proceeding to at least the summary judgment stage instead of being cut off at the outset, say Jeremiah Helm and Sean Murray at Knobbe Martens.
-
Proposed NIL Deal Leaves NCAA Antitrust Liability Door Open
The proposed House v. NCAA settlement filed in California federal court creates the possibility of significant direct payments to student-athletes for the first time, but the resulting framework is unlikely to withstand future antitrust scrutiny because it still represents an agreement among competitors to limit labor cost, says Yaman Desai at Lynn Pinker.
-
Opinion
Expert Witness Standards Must Consider Peer Review Crisis
For nearly two decades, the so-called replication crisis has upended how the scientific community views the reliability of peer-reviewed studies, and it’s time for courts to reevaluate whether peer review is a trustworthy proxy for expert witness reliability, say Jeffrey Gross and Robert LaCroix at Reid Collins.
-
USPTO Must Anticipate 'Black-Box Problem' For AI Inventions
The U.S. Patent and Trademark Office's recent guidance allows patents for inventions created with artificial intelligence, but inventors need to address the so-called black-box problem to ensure others can recreate the invention, thus meeting the enablement requirement, say Mark Basanta and Georg Reitboeck at Haug Partners.
-
Irish Businesses Should Act Now To Prepare For EU AI Act
Artificial intelligence is increasingly transforming the Irish job market, and proactive engagement with the forthcoming European Union AI Act, a significant shift in the regulatory landscape for Irish businesses, will be essential for Irish businesses to responsibly harness AI’s advantages and to maintain legal compliance, say lawyers at Pinsent Masons.
-
How To Grow Marketing, Biz Dev Teams In A Tight Market
Faced with fierce competition and rising operating costs, firms are feeling the pressure to build a well-oiled marketing and business development team that supports strategic priorities, but they’ll need to be flexible and creative given a tight talent market, says Ben Curle at Ambition.
-
Considerations For Federal Right Of Publicity As AI Advances
Amid rapid advances in generative artificial intelligence technology, Congress should consider how a federal right of publicity would interact with the existing patchwork of state name, image and likeness laws, as well as other issues like scope, harm recognized and available relief, says Ross Bagley at Pryor Cashman.
-
What Patent Litigators Should Know About CHIPS Act Grants
With the U.S. Department of Commerce now actively awarding grants under the CHIPS and Science Act, recipients should ensure they understand the implications of promises to construct new semiconductor manufacturing facilities, especially in jurisdictions with active patent litigation dockets, say Gabriel Culver and Peter Hillegas at Norton Rose.
-
Patent Lessons From 5 Federal Circuit Reversals In June
A look at June cases where the Federal Circuit reversed or vacated decisions by the Patent Trial and Appeal Board or a federal district court highlights a potential path for branded drugmakers to sue generic-drug makers for off-label uses, potential downsides of violating a pretrial order offering testimony, and more, say Denise De Mory and Li Guo at Bunsow De Mory.
-
Series
Rock Climbing Makes Me A Better Lawyer
Rock climbing requires problem-solving, focus, risk management and resilience, skills that are also invaluable assets in my role as a finance lawyer, says Mei Zhang at Haynes and Boone.
-
Think Like A Lawyer: Dance The Legal Standard Two-Step
From rookie brief writers to Chief Justice John Roberts, lawyers should master the legal standard two-step — framing the governing standard at the outset, and clarifying why they meet that standard — which has benefits for both the drafter and reader, says Luke Andrews at Poole Huffman.